Contents

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry, Volume 8 - Number 3

New Strategies and Biological Agents in the Treatment of Autoimmune Inflammatory Diseases. Progress and Challenges

, 8(3): 191 - 199

Rizgar A. Mageed


DOI: 10.2174/187152208785748377




Targeted Therapies – Many Ways to (the Peace of) Rome

, 8(3): 200 - 206

Martin Aringer and Josef S. Smolen


DOI: 10.2174/187152208785748296




Bone Changes in Patients with Inflammatory Arthritis Treated with Biological Therapies: A Clinical Perspective

, 8(3): 207 - 221

T. Baqai and A. S.M. Jawad


DOI: 10.2174/187152208785748304




Anti-CD20 in Targeting B Lymphocytes for the Treatment of Autoimmune Diseases: Clinical Benefits and Insights into the Role of B Lymphocytes in Pathophysiology

, 8(3): 222 - 234

Pierre Youinou, Taher E. Taher, Amani Mankai, Christian Berthou and Rizgar Mageed


DOI: 10.2174/187152208785748368




Appreciating the Balance between Classical Interleukin (IL)-6 Receptor Signaling and IL-6 Trans-Signaling: Implications for Arthritis Progression

, 8(3): 235 - 246

Simon A. Jones, Gareth W. Jones, Anwen S. Williams and Mari A. Nowell


DOI: 10.2174/187152208785748340




IL-17 and its Receptor Complex as Therapeutic Targets in Arthritis

, 8(3): 247 - 251

Myew-Ling Toh and Pierre Miossec


DOI: 10.2174/187152208785748331




Overview of the Role of Annexin 1 in the Innate and Adaptive Immune Response

, 8(3): 252 - 258

Fulvio D'Acquisto and Mauro Perretti


DOI: 10.2174/187152208785748313




“Cardiovascular” Drugs in Rheumatoid Arthritis: Killing Two Birds with One Stone?

, 8(3): 259 - 274

Tracey E. Toms, Vasileios F. Panoulas, Antonios Stavropoulos-Kalinoglou and George D. Kitas


DOI: 10.2174/187152208785748322




Novel Approaches to the Therapy of Rheumatoid Arthritis based on an Understanding of Disease Mechanisms

, 8(3): 275 - 284

Fiona E. McCann and Richard O. Williams


DOI: 10.2174/187152208785748359




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science